熱門資訊> 正文

United Therapeutics未能达到第一季度的预期

2026-05-06 18:38

聯合治療(UTHR) 0
TON(TON_USD.HASHKEY) 0

United Therapeutics press release (UTHR): Q1 GAAP EPS of $5.82 misses by $1.04.
Revenue of $781.5M (-1.6% Y/Y) misses by $15.88M.

More on United Therapeutics

United Therapeutics: The Future Lies With Manufactured Organs
United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win
United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade)
United Therapeutics Q1 2026 Earnings Preview
Smithfield Foods is the most overbought U.S. large-cap stock

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。